Thank you, Ms. Murray.
Today, as a Canadian researcher, I'm going to talk about my own perception of this issue, but first I want to introduce myself. I have an affiliation with the University of Montreal as a clinical adjunct professor and also as an associate professor at UQAM. I'm part of the Science Advisory Board for the U.S. EPA for the Exposure and Human Health Committee. I also coordinate the risk assessment and acceptability access, a new provincial network called NE3LS, which is the acronym for Nanotechnology Ethical, Environmental, Economic, Legal and Social Issues. I also started as a team leader in the International Team in Nanosafety a couple of years ago. This is a group from five different countries, France, Japan, U.S.A., Germany, and Canada. Recently, we added another platform called Nanotechnology Environmental Society and Health, which is led by Professor Louise Vandelac from UQAM.
During the last few years I have participated in several workshops and meetings in the U.S., Canada, Germany, and Japan, and these are my observations from this participation, discriminating between the pros and the cons of nanotechnology.